Home › Upcoming votes › Adagio Medical Holdings, Inc.
This meeting took place on October 23, 2026. Adagio Medical Holdings, Inc. reported the official results on Form 8-K, filed October 26, 2026 (read it on EDGAR); they are listed below.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Adagio Medical Holdings, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | APPROVAL OF A SERIES OF ALTERNATE AMENDMENTS TO OUR AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT OF OUR COMMON STOCK | Board | For | — |
From Adagio Medical Holdings, Inc.’s Form 8-K, filed December 16, 2025, for the meeting held December 15, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Todd Usen | 99.8% | Elected |
| Elect Director: James L. Cox, M.D. | 90% | Elected |
| 2. Ratification of the appointment of WithumSmith+Brown, PC as independent registered public accounting firm for the fiscal year ending Dece | 97% | — |
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| 1. Approval of a series of alternate amendments to the Company's Amended and Restated Certificate of Incorporation to effect, at the option | 94% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.